期刊文献+

心血管系统合理用药专家圆桌会议纪要 被引量:3

下载PDF
导出
摘要 去春千闲挂月,秋池共语济世,岁月轮回今又是,再瞻用药实事。承继倡导合理用药宗旨,由本刊主办的第4次心血管系统合理用药专家圆桌会议于8月21日在北京举行,出席专家圆桌会议的医、药学专家有华琦、汪家瑞、孙宁玲、孙忠实、吴学思、孙文萍、赵奎君、卢燕、刘红旭、鲁卫星、苗阳、黄进、张石革、吕强等,会议围绕高血压、高脂血、左心衰竭、脑卒中等药物治疗中的合理应用、不良反应预警等话题展开探讨,并达成共识。现整理后发表于此,期盼对临床治疗实践有所启迪和裨益!
出处 《中国医院用药评价与分析》 2007年第5期321-324,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献13

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2王文,马丽媛,李卫,吴海英.ACE抑制剂降压治疗对心脑血管事件影响的随机临床试验的汇总评估[J].高血压杂志,2005,13(4):202-208. 被引量:14
  • 3刘力生,龚兰生,王文,降压治疗预防卒中再发研究协作组.降压治疗对中国脑血管病患者脑卒中再发预防的多中心随机双盲对照临床研究[J].中华心血管病杂志,2005,33(7):613-617. 被引量:49
  • 4王文,刘明波,隋辉,马丽媛,刘力生.降低血压对心血管病高危患者益处的证据[J].中国循环杂志,2003,18(3):227-229. 被引量:18
  • 5Lisheng Liu. The study of hypertension in China [ J ]. Blood Pressure, 2004,13(2) :72.
  • 6Guidelines Committee. 2003 European Society of Hypertension European Society of Cardiology. Guidelines for the management of arterial hypertension:[ J ]. Journal of Hypertension, 2003,21(6):1 011.
  • 7World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization ( WHO ), International Society of Hypertension ( ISH ) statement on management of hypertension (Guidelines and recommendations) [ J ]. Journal of Hypertension, 2003,21 (11): 1 983.
  • 8Giles T. Relevance of blood pressure variation in the circadian onest of cardiovascular events [ J ]. Journal of Hypertension, 2005,23 ( Suppll ) : 35.
  • 9Kario K, Shimada K. Risers and extreme - dippres of noctm'anal blood pressure in hypertesion: antihypertensive strategy for nocturanal blood pressure [ J ]. Clin Exp Hypertense ,2004,26(2) : 177.
  • 10Aydin M, Ozeren A, Bilge M, et al. Left ventricular diastolic function and circadian variation of blood pressure in essential hypertesion [J]. Tex Hert Inst J ,2005,32( 1 ):28.

二级参考文献19

  • 1王文,刘力生.大规模心血管病临床试验的方法与结果评估[J].中华心血管病杂志,1993,21(5):309-311. 被引量:7
  • 2卡托普利对急性心肌梗死患者早期血压,心率的影响——中国心脏研究—Ⅰ暨...[J].高血压杂志,1996,4(3):165-168. 被引量:4
  • 3The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major Outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) [ J]. JAMA, 2002,288 : 2981-2997.
  • 4Wing LM,Reid CM,Ryan P,et al.For the second Australian national blood pressure study group.A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly[J].N Engl J Med,2003,348:583-592.
  • 5HOPE (Heart Outcomes Prevention Evaluation) study investigators,effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients[J].N Engl J Med,2000,342:145-153.
  • 6MacMahon S,Sharpe N, Gamble G,et al.Randomised,placebo-controlled trial of the angiotensin converting enzyme inhibitor,ramipril,in patients with coronary or other conclusive vascular disease[J].J Am Coil Cardiol,2000,36:438-443.
  • 7Cashin Hemphill L, Holmvang G,Chan RC,et al.Angiotensin converting enzyme inhibition as antiatherosclerotic therapy: no answer yet[J].Am J Cardiol,1999,83:43-47.
  • 8Teo KK,Burton JR, Buller CE,et al.Long-term effects of cholesterol lowering and angiotensin-converting-enzyme inhibition on coronary atherosclerosis:the simvastatin/enalapril coronary atherosclerosis trial (SCAT) [ J ].Circulation,2000,102:1748-1754.
  • 9PROGRESS Collaborative Group.Randomised trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack[J].Lancet,2001,358:1033-1041.
  • 10The EUROPA Invastigators.Efficancy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease:randomised,double-blind,placebo-con trolled,multicenter trial(the EROPA study)[J].Lancet,2003,362:782-788.

共引文献2694

同被引文献19

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部